Position in BDSX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,957,881
+$1,302,032 QoQ
Shares Held
86,824
+92.0% QoQ
Ownership
0.823%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 44 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $744,220,642 across 29 Diagnostics & Research names. BDSX ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
3,719,301 | $558,006,729 | |
| 2 | DHR |
Danaher Corp /De/
|
452,752 | $86,240,200 | |
| 3 | CDNA |
CareDx, Inc.
|
401,987 | $11,456,629 | |
| 4 | TWST |
Twist Bioscience Corp
|
94,600 | $9,732,448 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
48,191 | $9,311,465 | |
| 6 | MYGN |
Myriad Genetics Inc
|
1,557,727 | $8,894,621 | |
| 7 | NTRA |
Natera, Inc.
|
32,600 | $8,849,270 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
17,014 | $8,530,139 |
All Filings in BDSX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,957,881 | 86,824 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $655,849 | 45,231 | Shares | Sole | 2026-05-15 | |
| 2022-03-31 | $124,510 | 73,675 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $354,562 | 67,025 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $320,506 | 38,991 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||